Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Asta C 4898
2. Biopropazepan Trimethoxybenzoate
3. C 4898, Asta
4. Cormelian
5. Trimethoxybenzoate, Biopropazepan
1. 35898-87-4
2. Dilazep [inn]
3. F8klc2bd5z
4. Chembl126075
5. 3,3'-(1,4-diazepan-1,4-diyl)dipropyl Bis(3,4,5-trimethoxybenzoat)
6. Dilazep (inn)
7. Ncgc00016747-03
8. (1,4-diazepane-1,4-diyl)di(propane-3,1-diyl) Bis(3,4,5-trimethoxybenzoate)
9. Dsstox_cid_25425
10. Dsstox_rid_80871
11. Tetrahydro-1h-1,4-diazepine-1,4(5h)-dipropanol 3,4,5-trimethoxybenzoate (diester)
12. Dsstox_gsid_45425
13. Dilazepam
14. Dilazepum
15. 3-[4-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]-1,4-diazepan-1-yl]propyl 3,4,5-trimethoxybenzoate
16. Dilazepum [inn-latin]
17. Dilazepam [inn-spanish]
18. Benzoic Acid, 3,4,5-trimethoxy-,(tetrahydro-1h-1,4-diazepine-1,4(5h)-diyl)di-3,1-propanediyl Ester
19. Cas-35898-87-4
20. Unii-f8klc2bd5z
21. Benzoic Acid, 3,4,5-trimethoxy-, (tetrahydro-1h-1,4-diazepine-1,4(5h)-diyl)di-3,1-propanediyl Ester
22. Ki 2119
23. Tocris-0481
24. Dilazep [mi]
25. 20153-98-4
26. Prestwick0_000236
27. Prestwick1_000236
28. Prestwick2_000236
29. Prestwick3_000236
30. Dilazep [who-dd]
31. Lopac0_000369
32. Schembl48830
33. Bspbio_000311
34. Spbio_002232
35. Bpbio1_000343
36. Gtpl4717
37. Dtxsid9045425
38. Chebi:92842
39. Glxc-25687
40. Hms2090a11
41. 1,4-bis(3,4,5-trimethoxybenzyloxy)propyl)perhydro-1,4-diazepin
42. Tox21_110588
43. Bdbm50017691
44. Zinc22454221
45. 3,3'-(1,4-diazepan-1,4-diyl)dipropyl Bis(3,4,5-trimethoxybenzoat) [iupac]
46. Tox21_110588_1
47. Db13715
48. Ncgc00016747-01
49. Ncgc00016747-02
50. Ncgc00016747-04
51. Ncgc00016747-05
52. Ncgc00016747-07
53. Ncgc00024610-01
54. Ncgc00024610-02
55. 3-{4-[3-(3,4,5-trimethoxybenzoyloxy)propyl]-1,4-diazepan-1-yl}propyl 3,4,5-trimethoxybenzoate
56. Cas-20153-98-4
57. D07843
58. Q5276700
59. Sr-01000075817-3
60. Brd-k48722258-003-04-5
61. Brd-k48722258-300-03-7
62. Brd-k48722258-300-05-2
63. Brd-k48722258-300-07-8
64. (1,4-diazepane-1,4-diyl)bis(propane-3,1-diyl) Bis(3,4,5-trimethoxybenzoate)
65. 3,3'-(1,4-diazepane-1,4-diyl)bis(propane-3,1-diyl) Bis(3,4,5-trimethoxybenzoate)
66. 3,4,5-trimethoxybenzoic Acid 3-[4-[3-[oxo-(3,4,5-trimethoxyphenyl)methoxy]propyl]-1,4-diazepan-1-yl]propyl Ester
67. 8dz
| Molecular Weight | 604.7 g/mol |
|---|---|
| Molecular Formula | C31H44N2O10 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 18 |
| Exact Mass | 604.29959560 g/mol |
| Monoisotopic Mass | 604.29959560 g/mol |
| Topological Polar Surface Area | 115 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 727 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
C - Cardiovascular system
C01 - Cardiac therapy
C01D - Vasodilators used in cardiac diseases
C01DX - Other vasodilators used in cardiac diseases
C01DX10 - Dilazep
ABOUT THIS PAGE
A Dilazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dilazepam, including repackagers and relabelers. The FDA regulates Dilazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dilazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dilazepam supplier is an individual or a company that provides Dilazepam active pharmaceutical ingredient (API) or Dilazepam finished formulations upon request. The Dilazepam suppliers may include Dilazepam API manufacturers, exporters, distributors and traders.
Dilazepam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dilazepam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dilazepam GMP manufacturer or Dilazepam GMP API supplier for your needs.
A Dilazepam CoA (Certificate of Analysis) is a formal document that attests to Dilazepam's compliance with Dilazepam specifications and serves as a tool for batch-level quality control.
Dilazepam CoA mostly includes findings from lab analyses of a specific batch. For each Dilazepam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dilazepam may be tested according to a variety of international standards, such as European Pharmacopoeia (Dilazepam EP), Dilazepam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dilazepam USP).
LOOKING FOR A SUPPLIER?
